Medical Properties Trust (NYSE:MPW) had its price objective lifted by equities researchers at Robert W. Baird from $20.00 to $22.00 in a research note issued to investors on Tuesday, BenzingaRatingsTable reports. The brokerage presently has a “neutral” rating on the real estate investment trust’s stock. Robert W. Baird’s price target suggests a potential upside of 2.23% from the stock’s previous close.

Other research analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $24.00 price target on the stock in a research report on Wednesday, January 8th. Bank of America started coverage on shares of Medical Properties Trust in a report on Monday, October 14th. They issued a “neutral” rating and a $19.50 price objective for the company. ValuEngine raised shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Tuesday, December 3rd. TheStreet lowered shares of Medical Properties Trust from a “b” rating to a “c+” rating in a report on Monday, November 25th. Finally, Mizuho increased their target price on shares of Medical Properties Trust from $25.00 to $26.00 and gave the company a “buy” rating in a report on Thursday, December 26th. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $21.21.

Shares of MPW traded down $0.17 during midday trading on Tuesday, reaching $21.52. The stock had a trading volume of 21,287 shares, compared to its average volume of 3,442,297. The company has a current ratio of 6.27, a quick ratio of 6.27 and a debt-to-equity ratio of 1.02. The company has a market capitalization of $11.16 billion, a price-to-earnings ratio of 15.72, a price-to-earnings-growth ratio of 3.31 and a beta of 0.51. The company’s 50-day moving average is $20.76 and its 200 day moving average is $19.39. Medical Properties Trust has a 12-month low of $16.41 and a 12-month high of $21.71.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.32 by ($0.12). The firm had revenue of $224.70 million for the quarter, compared to analysts’ expectations of $221.40 million. Medical Properties Trust had a net margin of 41.57% and a return on equity of 6.36%. The business’s quarterly revenue was up 14.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.35 earnings per share. Research analysts forecast that Medical Properties Trust will post 1.32 EPS for the current fiscal year.

In other news, Director Michael G. Stewart sold 4,800 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $21.27, for a total value of $102,096.00. Also, COO Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction that occurred on Wednesday, January 8th. The stock was sold at an average price of $20.84, for a total transaction of $2,084,000.00. Following the completion of the transaction, the chief operating officer now owns 1,003,415 shares in the company, valued at approximately $20,911,168.60. The disclosure for this sale can be found here. Insiders own 1.18% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. 6 Meridian increased its position in shares of Medical Properties Trust by 2.8% in the fourth quarter. 6 Meridian now owns 30,944 shares of the real estate investment trust’s stock valued at $653,000 after acquiring an additional 841 shares during the period. IFM Investors Pty Ltd purchased a new stake in shares of Medical Properties Trust during the fourth quarter worth about $801,000. DNB Asset Management AS purchased a new stake in shares of Medical Properties Trust during the fourth quarter worth about $2,124,000. Advisors Capital Management LLC grew its stake in shares of Medical Properties Trust by 0.7% in the fourth quarter. Advisors Capital Management LLC now owns 679,144 shares of the real estate investment trust’s stock worth $14,337,000 after purchasing an additional 4,717 shares during the last quarter. Finally, Gateway Investment Advisers LLC grew its stake in shares of Medical Properties Trust by 8.3% in the fourth quarter. Gateway Investment Advisers LLC now owns 466,571 shares of the real estate investment trust’s stock worth $9,849,000 after purchasing an additional 35,672 shares during the last quarter. 71.92% of the stock is owned by institutional investors and hedge funds.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: How does a dividend reinvestment plan work?

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.